Presentation LAA 2017 Early and Late Results With the Wavecrest LAA Occluder (and Future Studies) Presenter: Gregg W. Stone July 22, 2017
Presentation LAA 2017 Transseptal Puncture for WATCHMAN LAA Occlusion Presenter: Amar Krishnaswamy July 21, 2017
Presentation LAA 2017 Watchman: Complication Frequency, Prevention, Recognition, and Management Presenter: Jacqueline Saw July 21, 2017
Presentation LAA 2017 Real-World Outcomes in Anticoagulation Indicated and Contraindicated Patients Presenter: Horst Sievert July 21, 2017
Presentation LAA 2017 Relational Anatomy of the Septum and Left Atrial Appendage Presenter: Mark Reisman July 21, 2017
Presentation LAA 2017 Watchman: Data Synthesis from RCTs and U.S. Registries Presenter: David R. Holmes July 21, 2017
Presentation LAA 2017 WATCHMAN LAA Closure: Device Description, Implantation Technique, Medications, and Follow-Up Presenter: Shephal Doshi July 21, 2017
Presentation LAA 2017 The Spectrum of LAA Closure Devices: Similarities and Differences Presenter: Horst Sievert July 21, 2017
Presentation LAA 2017 ICE for Trans-septal Puncture in an LAA Occlusion Procedure Presenter: Brij Maini July 21, 2017
Presentation LAA 2014 Watchman: Registry Data from the “Real-World” Presenter: Vivek Y. Reddy July 19, 2014
Presentation LAA 2014 Watchman: Randomized Trial Data in Anticoagulant Eligible Patients(from PROTECT AF to CAP to PREVAIL) Presenter: David R. Holmes July 19, 2014
Presentation LAA 2014 Watchman: Non-Randomized Trial Data in Anticoagulant Ineligible Patients ASAP and more Presenter: Vivek Y. Reddy July 19, 2014
Presentation LAA 2014 Do We Need More Data for Approving WATCHMAN? Presenter: Jay N. Koneru July 18, 2014
Presentation LAA 2014 LAA Closure: The Device, Attribute and Basic Technique- The Watchman Device - Presenter: Saibal Kar July 17, 2014